|
Official Journal |
EN L series |
REGULATION (EU) 2025/13 OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL
of 19 December 2024
on the collection and transfer of advance passenger information for the prevention, detection, investigation and prosecution of terrorist offences and serious crime, and amending Regulation (EU) 2019/818
THE COUNCIL OF THE EUROPEAN UNION,
Having regard to the Treaty establishing the European Community,
Having regard to Regulation (EC) No 726/2004 of the European Parliament and of the Council of 31 March 2004 laying down Community procedures for the authorisation and supervision of medicinal products for human and veterinary use and establishing a European Medicines Agency (1), and in particular Article 65(1) and Article 65(4) thereof,
Having regard to the list of candidates drawn up by the Commission on 16 September 2008,
Having regard to the opinion of the European Parliament,
HAS DECIDED AS FOLLOWS:
Having regard to the Treaty establishing the European Community,
Having regard to Regulation (EC) No 726/2004 of the European Parliament and of the Council of 31 March 2004 laying down Community procedures for the authorisation and supervision of medicinal products for human and veterinary use and establishing a European Medicines Agency (1), and in particular Article 65(1) and Article 65(4) thereof,
Having regard to the list of candidates drawn up by the Commission on 16 September 2008,
Having regard to the opinion of the European Parliament,
HAS DECIDED AS FOLLOWS:
Ms Mary G. BAKER, born in London (United Kingdom) on 27 October 1936,
Mr Mike O'DONOVAN, born in London (United Kingdom) on 26 September 1946,
Ms Lisette TIDDENS-ENGWIRDA, born in Amsterdam (Netherlands) on 25 June 1950
and
Mr Henk VAARKAMP, born in Terschuur (Netherlands) on 22 June 1950,
are hereby appointed members of the Management Board of the European Medicines Agency (EMEA) for a period of three years.
The date on which the three-year period referred to in Article 1 will commence shall be determined by the Management Board of the European Medicines Agency (EMEA).
(1) OJ L 136, 30.4.2004, p. 1.
(1) OJ L 136, 30.4.2004, p. 1.
ELI: http://data.europa.eu/eli/dec/2009/75(1)/oj